Management of Female Stress Urinary Incontinence
Keywords:
Female Stress Urinary IncontinenceAbstract
ภาวะปัสสาวะเล็ดขณะไอ จามในสตรี เป็นหนึ่งในกลุ่มอาการระบบทางเดินปัสสาวะส่วนล่าง (Lower urinary tract symptoms) ที่พบได้บ่อยในสตรี แม้ว่าไม่ได้เป็นภาวะที่รุนแรงหรือเป็นอันตรายต่อชีวิต แต่มีข้อมูลจากหลายการศึกษาพบว่า ภาวะดังกล่าวก่อให้เกิดผลกระทบในทางลบต่อคุณภาพชีวิต การให้ความใส่ใจในการดูแลรักษาสตรีที่ประสบปัญหาภาวะดังกล่าวจะส่งผลให้สตรีกลุ่มนี้มีสุขภาพและคุณภาพชีวิตที่ดียิ่งขึ้น ปัจจุบันเริ่มมีการใช้สเต็มเซลล์มาใช้ในการกระตุ้นเนื้อเยื่อบริเวณกล้ามเนื้อรอบท่อปัสสาวะให้ทำงานได้ดีขึ้น และพัฒนาสารที่ออกฤทธิ์โดยตรงต่อตัรับ Adrenergic และ Serotonergic เพื่อให้ได้ผลการรักษาที่มีประสิทธิภาพยิ่งขึ้น ซึ่งยังคงต้องทำการศึกษาเพิ่มเติมต่อไป
References
Manonai J, Chittacharoen A, Sarit-apirak S, Udomsubpayakul U, Khanacharoen A, Theppisai U. Lower urinary tract symptoms in Thai women attending the menopause clinic: prevalence and associated factors. J Med Assoc Thai. 2004;87(11):1265-9.
Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311-6. doi:10.1001/jama.300.11.1311.
Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol. 2008;111(3):678-85. doi:10.1097/AOG.0b013e3181660c1b.
Wattanayingcharoenchai R, Manonai J, Vannatim N, Saritapirak S, Imsomboon C, Chittacharoen A. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic. J Med Assoc Thai. 2007;90(1):26-31.
Haylen BT1, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798.
Latthe PM, Foon R, Khan K. Nonsurgical treatment of stress urinary incontinence (SUI): grading of evidence in systematic reviews. BJOG. 2008;115(4):435-44. doi: 10.1111/j.1471-0528.2007.01629.x.
Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008;148(6):459-73.
Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 1996;87(5 Pt 1):715-21.
Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174(1):190-5.
Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481-90. doi:10.1056/NEJMoa0806375.
Berghmans LC, Hendriks HJ, Bo K, Hay-Smith EJ, de Bie RA, van Waalwijk van Doorn ES. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol. 1998;82(2):181-91.
Dumoulin C, Hay-Smith EJ, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(5):CD005654. doi:10.1002/14651858.CD005654.pub3.
Aksac B, Aki S, Karan A, Yalcin O, Isikoglu M, Eskiyurt N. Biofeedback and pelvic floor exercises for the rehabilitation of urinary stress incontinence. Gynecol Obstet Invest. 2003;56(1):23-7.
Herderschee R, Hay-Smith EJ, Herbison GP, Roovers JP, Heineman MJ. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011;(7):CD009252. doi:10.1002/14651858.CD009252.
Hay-Smith J, Herderschee R, Dumoulin C, Herbison P. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women: an abridged Cochrane systematic review. Eur J Phys Rehabil Med. 2012;48(4):689-705.
Bø K, Hilde G. Does it work in the long term?--A systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn. 2013;32(3):215-23. doi:10.1002/nau.22292.
Bhatia NN, Bergman A, Gunning JE. Urodynamic effects of a vaginal pessary in women with stress urinary incontinence. Am J Obstet Gynecol. 1983;147(8):876-84.
Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol. 2007;196(4):405.e1-8.
Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025-9.
Farrell SA, Singh B, Aldakhil L. Continence pessaries in the management of urinary incontinence in women. J Obstet Gynaecol Can. 2004;26(2):113-7.
Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115(3):609-17. doi: 10.1097/AOG.0b013e3181d055d4.
Steinauer JE, Waetjen LE, Vittinghoff E, et al. Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol. 2005;106(5 Pt 1):940-5.
Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293(8):935-48.
Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:CD001405. doi:10.1002/14651858.CD001405.pub3.
Holtedahl K, Verelst M, Schiefloe A. A population based, randomized, controlled trial of conservative treatment for urinary incontinence in women. Acta Obstet Gynecol Scand. 1998;77(6):671-7.
Moore K. Duloxetine: a new approach for treating stress urinary incontinence. Int J Gynaecol Obstet. 2004;86 Suppl 1:S53-62.
Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002;187(1):40-8.
Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol. 2003;170(4 Pt 1):1259-63.
Ghoniem GM, Van Leeuwen JS, Elser DM, et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol. 2005;173(5):1647-53.
Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol. 2007;51(1):67-74.
Li J, Yang L, Pu C, Tang Y, Yun H, Han P. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol. 2013;45(3):679-86. doi:10.1007/s11255-013-0410-6.
Abrams P, Hilton P, Lucas M, Smith T. A proposal for a new classification for operative procedures for stress urinary incontinence. BJU Int. 2005;96(3):232-3.
Lapitan MC, Cody JD, Grant A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2009;(2):CD002912. doi:10.1002/14651858.CD002912.pub3.
Glazener CM, Cooper K. Anterior vaginal repair for urinary incontinence in women. Cochrane Database Syst Rev. 2001;1:CD001755.
Jarvis GJ. Surgery for genuine stress incontinence. Br J Obstet Gynaecol. 1994;101(5):371-4.
Czaplicki M, Dobroński P, Torz C, Borkowski A. Long-term subjective results of Marshall-Marchetti-Krantz procedure. Eur Urol. 1998;34(2):118-23.
Kinn AC. Burch colposuspension for stress urinary incontinence. 5-year results in 153 women. Scand J Urol Nephrol. 1995;29(4):449-55.
Alcalay M1, Monga A, Stanton SL. Burch colposuspension: a 10-20 year follow up. Br J Obstet Gynaecol. 1995 Sep;102(9):740-5.
Carey MP, Goh JT, Rosamilia A, et al. Laparoscopic versus open Burch colposuspension: a randomised controlled trial. BJOG. 2006;113(9):999-1006.
Dean NM, Ellis G, Wilson PD, Herbison GP. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2006;3:CD002239.
Glazener CM, Cooper K. Bladder neck needle suspension for urinary incontinence in women. Cochrane Database Syst Rev. 2004;2:CD003636.
Tebyani N, Patel H, Yamaguchi R, Aboseif SR. Percutaneous needle bladder neck suspension for the treatment of stress urinary incontinence in women: long-term results. J Urol. 2000;163(5):1510-2.
Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011;1:CD001754. doi:10.1002/14651858.CD001754.pub3.
Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009;4:CD006375. doi:10.1002/14651858.CD006375.pub2.
Madhuvrata P, Riad M, Ammembal MK, Agur W, Abdel-Fattah M. Systematic review and meta-analysis of "inside-out" versus "outside-in" transobturator tapes in management of stress urinary incontinence in women. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):1-10. doi:10.1016/j.ejogrb.2012.01.004.
Kennelly MJ, Moore R, Nguyen JN, Lukban JC, Siegel S. Prospective evaluation of a single incision sling for stress urinary incontinence. J Urol. 2010;184(2):604-9. doi:10.1016/j.juro.2010.04.003.
Abdel-Fattah M, Ford JA, Lim CP, Madhuvrata P. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur Urol. 2011;60(3):468-80. doi:10.1016/j.eururo.2011.05.003.
Walsh CA. TVT-Secur mini-sling for stress urinary incontinence: a review of outcomes at 12 months. BJU Int. 2011;108(5):652-7. doi:10.1111/j.1464-410X.2011.10333.x.
Kennelly MJ, Moore R, Nguyen JN, Lukban J, Siegel S. Miniarc single-incision sling for treatment of stress urinary incontinence: 2-year clinical outcomes. Int Urogynecol J. 2012;23(9):1285-91. doi:10.1007/s00192-012-1734-y.
Atherton MJ, Stanton SL. The tension-free vaginal tape reviewed: an evidence-based review from inception to current status. BJOG. 2005;112(5):534-46.
Roumeguère T, Quackels T, Bollens R, et al. Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients. Eur Urol. 2005;48(5):805-9.
Andersen RC. Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence. J Low Genit Tract Dis. 2002;6(4):239-43.
Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012;(2):CD003881. doi:10.1002/14651858.CD003881.pub3.
Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J. 2013;24(1):27-36. doi:10.1007/s00192-012-1825-9.
Webster GD, Perez LM, Khoury JM, Timmons SL. Management of type III stress urinary incontinence using artificial urinary sphincter. Urology. 1992;39(6):499-503.
.png){kind=logo}
